Business Description
Organovo Holdings Inc
NAICS : 541714
SIC : 2836
ISIN : US68620A2033
Description
Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.53 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -57.3 | |||||
| Beneish M-Score | -4.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -50.1 | |||||
| 3-Year EBITDA Growth Rate | 13.9 | |||||
| 3-Year EPS without NRI Growth Rate | 11.9 | |||||
| 3-Year FCF Growth Rate | 13.8 | |||||
| 3-Year Book Growth Rate | -24.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.17 | |||||
| 9-Day RSI | 41.45 | |||||
| 14-Day RSI | 44.74 | |||||
| 6-1 Month Momentum % | -9.57 | |||||
| 12-1 Month Momentum % | -43.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.67 | |||||
| Quick Ratio | 3.67 | |||||
| Cash Ratio | 3.11 | |||||
| Days Sales Outstanding | 140.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 3.92 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -8169.01 | |||||
| Net Margin % | -7886.36 | |||||
| FCF Margin % | -6975.11 | |||||
| ROE % | -149.03 | |||||
| ROA % | -119 | |||||
| ROIC % | -517.48 | |||||
| ROC (Joel Greenblatt) % | -819.41 | |||||
| ROCE % | -141.06 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 34.07 | |||||
| PB Ratio | 1.57 | |||||
| Price-to-Tangible-Book | 1.54 | |||||
| EV-to-EBIT | -0.32 | |||||
| EV-to-EBITDA | -0.33 | |||||
| EV-to-Revenue | 25.9 | |||||
| EV-to-FCF | -0.36 | |||||
| Price-to-Net-Current-Asset-Value | 2.76 | |||||
| Price-to-Net-Cash | 3.79 | |||||
| Earnings Yield (Greenblatt) % | -317.24 | |||||
| FCF Yield % | -168.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Organovo Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.225 | ||
| EPS (TTM) (€) | -2.017 | ||
| Beta | 1.79 | ||
| Volatility % | 36.76 | ||
| 14-Day RSI | 44.74 | ||
| 14-Day ATR (€) | 0.069744 | ||
| 20-Day SMA (€) | 1.00545 | ||
| 12-1 Month Momentum % | -43.67 | ||
| 52-Week Range (€) | 0.822 - 1.792 | ||
| Shares Outstanding (Mil) | 10.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Organovo Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Organovo Holdings Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Organovo Holdings Inc Frequently Asked Questions
What is Organovo Holdings Inc(STU:4OR1)'s stock price today?
The current price of STU:4OR1 is €0.91. The 52 week high of STU:4OR1 is €1.79 and 52 week low is €0.82.
When is next earnings date of Organovo Holdings Inc(STU:4OR1)?
The next earnings date of Organovo Holdings Inc(STU:4OR1) is 2024-08-09 Est..
Does Organovo Holdings Inc(STU:4OR1) pay dividends? If so, how much?
Organovo Holdings Inc(STU:4OR1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers